The Monitor Market Has Changed
For decades, the standard blood sugar monitor was a simple meter, a lancet, and a vial of test strips. That approach still works and remains the cheapest option for many Americans. A basic meter and a box of 50 strips can run well under $20 at retailers like Walmart, where store brands such as ReliOn and Equate keep costs reasonable. That matters for people who test a few times a day and want predictable, low-cost supplies.
What changed the conversation is the continuous glucose monitor, or CGM. A CGM uses a tiny sensor worn on the upper arm that measures glucose in the fluid just under the skin every few minutes. Instead of a snapshot at mealtime, you get a rolling picture of how food, exercise, stress, and sleep move your numbers. The FDA cleared the first over-the-counter CGMs in 2024, which opened the door for people with type 2 diabetes, prediabetes, and even curious healthy adults to buy one without a prescription.
That shift created a new problem: too many options. Prescription CGMs like Dexcom G7 and FreeStyle Libre 3 remain the standard for people on insulin, and Medicare now covers them under expanded rules that no longer require multiple daily injections. Meanwhile, OTC devices like Dexcom Stelo and Abbott Lingo target people not on insulin who simply want metabolic insight. Choosing between them depends on your health status, your budget, and how much coaching you want built into the app.
What Each Option Really Costs
The pricing picture for blood sugar monitors in the US splits into two very different worlds. Traditional meters use a pay-per-strip model where the meter itself is often inexpensive, sometimes under $20, but the strips become the recurring cost. A box of 50 generic strips might cost between $7 and $20, while name-brand strips from companies like Accu-Chek or Contour can run $20 to $60 for the same quantity depending on the retailer and pack size. If you test twice a day, that works out to a modest monthly outlay, and many private plans cover strips under pharmacy benefits.
CGMs operate on a subscription or per-sensor model. Dexcom Stelo, the first OTC glucose biosensor cleared by the FDA, sells a two-sensor box for around $99, with a monthly subscription at about $89 and a three-month plan around $252. Abbott Lingo offers a one-time two-week sensor for about $49 and a 12-week subscription around $249, which averages out to roughly $83 per month. Prescription CGMs look different: Dexcom G7 runs roughly $60 to $100 per month paid in cash, and Abbott's coverage data shows that most insured patients with Libre pay between $0 and $20 per month. Medicare beneficiaries who qualify typically face modest copays, and dual-eligible patients often pay nothing out of pocket.
| Product | Type | Typical Price | Best For | Pros | Cons |
|---|
| ReliOn / Equate meters | Traditional | Strips $7–$20 per 50 | Budget testers | Cheap supplies, no prescription | Snapshot readings only |
| Accu-Chek Guide | Traditional | Strips $20–$60 per 50 | Name-brand reliability | Accurate, widely available | Higher strip cost |
| Dexcom Stelo | OTC CGM | ~$89–$99 per month | Type 2 not on insulin | No prescription, simple app | No urgent alerts |
| Abbott Lingo | OTC CGM | ~$49–$89 per month | Budget CGM beginners | Built-in coaching, low entry price | Automated coaching only |
| Dexcom G7 | Prescription CGM | ~$60–$100 per month cash | Insulin users, T1/T2 | Real-time alerts, pump compatible | Requires prescription |
| FreeStyle Libre 3 | Prescription CGM | Most insured pay $0–$20/mo | Broad diabetes management | Strong insurance coverage | Requires clinician order |
Matching the Monitor to Your Situation
A 58-year-old in San Antonio managing type 2 diabetes with metformin has different needs than a 34-year-old runner in Portland who wants to see how oatmeal spikes her glucose. The first person might do fine with an OTC biosensor like Stelo, which is designed for adults not on insulin who want to understand how lifestyle choices affect their numbers. It delivers a clean daily insight summary without the alarm fatigue that comes with medical-grade devices.
The runner, on the other hand, might prefer Abbott Lingo, which turns glucose data into a coaching score and emphasizes habit building rather than clinical management. Lingo is not cleared for diabetes diagnosis, but as a wellness tool it appeals to people who want structured feedback on meals and workouts. For anyone on insulin, though, neither OTC option fits. Prescription CGMs with real-time alerts and insulin pump compatibility are the medically appropriate choice, and insurance coverage makes them the economical one for most.
Sarah from Columbus, Ohio, discovered this distinction the hard way. Her father, a retired teacher with type 2 diabetes, was not on insulin and had been pricking his fingers four times a day for years. She bought him a Stelo two-pack as a trial, and within two weeks they could see exactly which dinners pushed his glucose past the target range. The insight was so useful that they moved to the monthly subscription. The cost felt acceptable compared with the constant strip purchases, and his follow-up A1C appointment reflected the improvement.
Practical Steps to Get Started
Start by checking what your insurance already covers, because that single step can save you hundreds of dollars. Medicare Part B now covers therapeutic CGMs for anyone on insulin and for certain people with documented low blood sugar events, provided a clinician documents the need and you complete a qualifying visit within six months before the order. Private insurers like Aetna, Cigna, and UnitedHealthcare generally cover CGMs for type 1 diabetes and for type 2 patients on insulin, though prior authorization is often required. The ADCES coverage lookup tool lets you search by insurer and state to see exactly where you stand.
If you are paying out of pocket, decide between the strip route and the sensor route by counting your testing frequency. A twice-daily fingerstick routine with a store-brand meter can cost less than $15 per month in supplies, which is hard to beat for pure budget. But if you want trend data, pattern detection, and the ability to see how a specific meal affects you for hours afterward, an OTC CGM at roughly $50 to $99 per month delivers insight that strips cannot.
For people leaning toward a CGM, several states have expanded pharmacy-benefit access for these devices, which simplifies getting sensors filled at a local pharmacy. Twenty-nine states now allow CGMs through the pharmacy benefit, often with little or no out-of-pocket cost for covered patients. Check with your state's Medicaid program if you are enrolled, since coverage varies considerably from state to state, with some states offering no CGM coverage for most recipients and others covering them fully.
A Smarter Way to Track Your Numbers
Whatever you choose, the goal is the same: understand your glucose patterns well enough to act on them. A $15 box of strips gives you data points; a $99 sensor gives you a story. Many Americans start with a traditional meter for daily checks and add an OTC biosensor for a month or two to map their response to food and activity. That hybrid approach keeps costs down while building the awareness that leads to lasting changes. Talk to your clinician about which device fits your diagnosis and your budget, then check manufacturer assistance programs and your insurer's formulary before you buy. The right blood sugar monitor is the one you will actually use consistently, and in 2026 that has never been more attainable.
研究の知恵